Skip to main content

Doctors turning to trusted life hack to eliminate pain of perfectionism

The hair-splitting and nitpicking pain of perfectionism can cause many people to overthink, stress or burnout.

But an old life hack is surging that’s designed to eliminate anxiety linked to making perfect choices and spark quick action.

It’s called “satisficing,” a combination of making choices that are satisfying and suffice with the information that’s readily available.

Dr. Tina Thomas, an adult psychiatrist at Kaiser Permanente, said it means a quick escape from analysis paralysis for many perfectionists.

“As humans, we have this desire to want to make the right choice all of the time. And not do something until we are 100% prepared. But in that desire, we end up not really achieving a lot,” she told WTOP.

The decision-making strategy was first used back in the mid-1950s by Dr. Herbert Simon. He taught patients to make choices based on their first “good-enough” option that met their needs, rather than the perfect choice. It helped reduce anxiety and rumination.

“It’s about being good enough rather than perfect,” she said.

In addition to the method, Thomas advises her patients to set and stick to clear deadlines, and once a decision is made, don’t second-guess it.

“Be happy. You’ve made a good choice,” she said. “Know that your task is done and you can move forward.”

Tools to fight hantavirus show promise despite limited funding. Now researchers hope to continue

SANTIAGO, Chile (AP) — When a rare but deadly rodent-borne virus struck passengers on a cruise ship and seemed to be spreading, there were no treatments for those who fell ill and no vaccines to protect others. That was the case even though it wasn't a novel germ that the world had never seen before, like the virus that caused the coronavirus pandemic. It was a hantavirus, one of a family of viruses that have been known for decades and are thought to exist around the world. Teams of researchers, including in Chile, Argentina and the United States, have long been trying to find and develop drugs and vaccines. But because the viruses are relatively rare and don't spread easily between people, there hasn't been enough sustained investment by governments, global health groups, or drug companies to pay for the extensive safety and efficacy testing needed to make them available. Still, there have been some promising developments. Researchers on Wednesday published a hint that a drug used for an autoimmune disease may help hantavirus patients fight off the most deadly symptoms.
Read Next Story